EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Clinical Characteristics Treatment Approaches and Survival Outcomes in Secondary Hemophagocytic Lymphohistiocytosis: A Retrospective Observational Study

Amratansh Varshney, Pratibha Satish Phadke, Anusree Prabhakaran, Dipak Patade, Yash Bhalani, Abhishek Kumar

Journal of The Association of Physicians of India · 2026

DOI: 10.59556/japi.74.1607 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of The Association of Physicians of India, 2026. Verfasst von Amratansh Varshney und 5 weiteren Autor:innen. Beteiligte Einrichtung: Senior Registrar, Department of Internal Medicine, Deenanath Mangeshkar Hospital, Pune, Maharashtra, India. Hauptthemen laut MEDLINE: Lymphohistiocytosis, Hemophagocytic, Dexamethasone, Etoposide. Die Arbeit nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Hemophagocytic lymphohistiocytosis (HLH) is a rare but potentially fatal syndrome characterized by immune hyperactivation and a cytokine storm, leading to fever, cytopenia, organomegaly, and multiorgan dysfunction. Given its high morbidity and mortality, prompt diagnosis and treatment are essential. Currently, there are no established markers to predict outcomes in secondary hemophagocytic lymphohistiocytosis (sHLH). MATERIALS AND METHODS: This retrospective study aimed to identify prognostic factors in patients with sHLH, specifically evaluating the prognostic role of absolute neutrophil count (ANC) and serum ferritin level. The study also examined the impact of dexamethasone and etoposide on the treatment of these patients. RESULTS: HLH remission was achieved in 64 patients (71.1%). Forty-seven out of those 64 patients survived and were discharged home, while 17 patients died in the hospital. HLH remission was not achieved in 26 patients (28.9%), of whom 25 patients died in the hospital. ANC at diagnosis and lower nadir ANC during the hospital stay significantly correlated with mortality (p = 0.001 and 0.017, respectively). Serum ferritin levels, however, were not a significant prognostic marker (p = 0.396). Treatment with dexamethasone was associated with better outcomes in patients with sHLH. CONCLUSION: sHLH should be considered in patients with treatment-resistant bicytopenia or pancytopenia. Lower ANC at diagnosis and nadir ANC during hospitalization are associated with increased mortality, suggesting that ANC is a potential indicator for early immunochemotherapy. Serum ferritin level is not a significant prognostic marker. Early diagnosis and dexamethasone treatment help achieve HLH remission, which improves outcomes in sHLH. These findings highlight the need for prospective studies to better understand sHLH prognostic markers and therapeutic strategies, especially in intensive care settings, where mortality remains high.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphohistiocytosis, HemophagocyticDexamethasoneEtoposideHumansFemaleRetrospective StudiesMalePrognosisFerritinsTreatment OutcomeAdolescentChildGlucocorticoidsChild, PreschoolAdultNeutrophilsLeukocyte CountRemission InductionYoung Adult

Substanzen

DexamethasoneEtoposideFerritinsGlucocorticoids

Autor:innen und Institutionen

  • Senior Registrar, Department of Internal Medicine, Deenanath Mangeshkar Hospital, Pune, Maharashtra, India.
  • Consulting Physician, Department of Internal Medicine, Deenanath Mangeshkar Hospital, Pune, Maharashtra, India.
  • Consultant, Department of Clinical Hematology, Deenanath Mangeshkar Hospital, Pune, Maharashtra, India.
  • Resident, Department of Cardiology, Deenanath Mangeshkar Hospital, Pune, Maharashtra, India.
  • Consultant, Department of Critical Care Medicine, PD Hinduja Hospital, Mumbai, Maharashtra, India.
  • Associate Professor, Department of Cardiology, Government Superspeciality Hospital CIMS, Bilaspur, Chhattisgarh, India, Corresponding Author.

Zitieren

APA

Varshney, A., Phadke, P. S., Prabhakaran, A., Patade, D., Bhalani, Y., & Kumar, A. (2026). Clinical Characteristics Treatment Approaches and Survival Outcomes in Secondary Hemophagocytic Lymphohistiocytosis: A Retrospective Observational Study. Journal of The Association of Physicians of India. https://doi.org/10.59556/japi.74.1607

Vancouver

Varshney A, Phadke PS, Prabhakaran A, Patade D, Bhalani Y, Kumar A. Clinical Characteristics Treatment Approaches and Survival Outcomes in Secondary Hemophagocytic Lymphohistiocytosis: A Retrospective Observational Study. Journal of The Association of Physicians of India. 2026. doi:10.59556/japi.74.1607

BibTeX
@article{Varshney2026,
  author = {Varshney, Amratansh and Phadke, Pratibha Satish and Prabhakaran, Anusree and Patade, Dipak and Bhalani, Yash and Kumar, Abhishek},
  title = {Clinical Characteristics Treatment Approaches and Survival Outcomes in Secondary Hemophagocytic Lymphohistiocytosis: A Retrospective Observational Study},
  journal = {Journal of The Association of Physicians of India},
  year = {2026},
  doi = {10.59556/japi.74.1607}
}
Kostenlos starten →